Beaird Harris Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$134K Buy
5,560
+1,663
+43% +$43.5K 0.01% 182
2026
Q1
$109K Sell
3,897
-486
-11% -$12.9K 0.01% 180
2025
Q4
$109K Buy
4,383
+213
+5% +$5.37K 0.01% 183
2025
Q3
$106K Sell
4,170
-13,950
-77% -$344K 0.01% 175
2025
Q2
$439K Buy
18,120
+13,550
+296% +$316K 0.03% 93
2025
Q1
$116K Sell
4,570
-282
-6% -$7.38K 0.01% 156
2024
Q4
$129K Buy
4,852
+1,100
+29% +$29.8K 0.01% 149
2024
Q3
$109K Sell
3,752
-2,489
-40% -$72.6K 0.01% 170
2024
Q2
$175K Sell
6,241
-56
-0.9% -$1.54K 0.02% 130
2024
Q1
$175K Sell
6,297
-1,438
-19% -$39.9K 0.02% 126
2023
Q4
$223K Buy
7,735
+9
+0.1% +$272 0.02% 104
2023
Q3
$256K Buy
7,726
+641
+9% +$22.7K 0.03% 84
2023
Q2
$260K Hold
7,085
0.03% 86
2023
Q1
$289K Sell
7,085
-478
-6% -$20.6K 0.05% 74
2022
Q4
$388K Buy
7,563
+478
+7% +$22.9K 0.07% 62
2022
Q3
$310K Buy
7,085
+1,614
+30% +$78.4K 0.07% 60
2022
Q2
$287K Sell
5,471
-660
-11% -$33.6K 0.08% 57
2022
Q1
$317K Sell
6,131
-250
-4% -$13K 0.11% 65
2021
Q4
$377K Buy
+6,381
New +$316K 0.14% 72

Other funds holding PFE

Beaird Harris Wealth Management's PFE Position: Q2 2026 in Review

Beaird Harris Wealth Management increased its Pfizer (PFE) stake by 43% in Q2 2026, buying an estimated $43.5K and bringing the position to 5,560 shares worth $134K. The position accounts for 0.01% of the portfolio, ranked #182.

Beaird Harris Wealth Management first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $439K in Q2 2025. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Beaird Harris Wealth Management held 5,560 shares of Pfizer worth $134K as of Q2 2026.
  • Beaird Harris Wealth Management bought 1,663 Pfizer shares in Q2 2026, an estimated $43.5K.
  • Pfizer made up 0.01% of Beaird Harris Wealth Management's portfolio in Q2 2026, its #182 holding.
  • Beaird Harris Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Beaird Harris Wealth Management's Pfizer position peaked at $439K in Q2 2025.
  • 491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Beaird Harris Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.